...
首页> 外文期刊>Sri Lanka Journal of Psychiatry >Tobacco smoking in persons with schizophrenia followed up at a teaching hospital in Sri Lanka
【24h】

Tobacco smoking in persons with schizophrenia followed up at a teaching hospital in Sri Lanka

机译:在斯里兰卡的一家教学医院对精神分裂症患者的吸烟进行了追踪

获取原文
           

摘要

Background Studies in Western populations indicate that the prevalence of smoking in patients with schizophrenia ranges from 70-90%. Data from low and middle income countries is sparse. Aims To determine the prevalence of smoking in patients with schizophrenia, and to identify probable associations. Methodology The study was conducted at the psychiatry outpatient clinics of Colombo North Teaching Hospital, Ragama. Consecutive outpatients who met ICD-10 diagnostic criteria for schizophrenia were invited to answer an interviewer administered, pre-tested questionnaire on socio-demographic status, smoking habits, disease and treatment related characteristics. The Fagerstrom’s Test for Nicotine Dependence was used to grade the level of nicotine addiction. Results Of the 400 patients with schizophrenia, 171 (42.8%) were smokers. Of them 150 (87.7%) were dependent on nicotine. In terms of Fagerstrom’s Test, high dependence was seen in 3.3% (n=5) while 39.2% (n=59) and 57.3% (n=86) reported moderate and low dependence respectively. All the smokers were male. For a majority of the patients the age of initiation of smoking was between 16-25 years, correlating with the onset of schizophrenia. Interestingly, most of the smokers (63.2%) were keen to quit smoking. Participants who smoked were significantly more likely to misuse other substances (p=0.001) and to suffer from physical illnesses (p=0.0001), compared to non-smokers. Smokers were also significantly more likely to be on intramuscular depot antipsychotics (p=0.032), whereas non-smokers in contrast, were more likely to be on atypical antipsychotics (p=0.0001). Conclusion A dual diagnosis of schizophrenia and nicotine dependence could be made in nearly half of our study population with schizophrenia. Although these rates are lower than in western populations, it is an issue that needs to be addressed in the treatment. DOI: http://dx.doi.org/10.4038/sljpsyc.v5i2.7816Sri Lanka Journal of Psychiatry Vol 5(2):19-23
机译:西方人群的背景研究表明,精神分裂症患者的吸烟率在70-90%之间。来自中低收入国家的数据很少。目的确定精神分裂症患者的吸烟率,并确定可能的关联。方法论该研究是在拉加马的科伦坡北部教学医院的精神科门诊进行的。符合ICD-10精神分裂症诊断标准的连续门诊患者应邀回答访调员管理的,经过预先测试的调查问卷,内容涉及社会人口状况,吸烟习惯,疾病和治疗相关特征。 Fagerstrom的尼古丁依赖性测试用于评估尼古丁成瘾水平。结果在400名精神分裂症患者中,吸烟者为171名(42.8%)。其中有150名(87.7%)依赖尼古丁。根据Fagerstrom检验,有3.3%(n = 5)的高依赖性,而有39.2%(n = 59)和57.3%(n = 86)的中度和低依赖性。所有吸烟者都是男性。对于大多数患者,开始吸烟的年龄在16-25岁之间,与精神分裂症的发作有关。有趣的是,大多数吸烟者(63.2%)渴望戒烟。与不吸烟者相比,吸烟者更容易滥用其他物质(p = 0.001)并患有身体疾病(p = 0.0001)。吸烟者也更可能在肌肉内使用抗精神病药(p = 0.032),而非吸烟者则更可能使用非典型抗精神病药(p = 0.0001)。结论在将近一半的精神分裂症患者中,可以对精神分裂症和尼古丁依赖性进行双重诊断。尽管这些比率低于西方人群,但这是在治疗中需要解决的问题。 DOI:http://dx.doi.org/10.4038/sljpsyc.v5i2.7816斯里兰卡《精神病学杂志》第5卷第2期:19-23

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号